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OBJECTIVES This study was designed to determine if a subset of patients who have undergone bidirectional
cavopulmonary anastomosis could be identified in which catheterization was of little benefit
before completion of the Fontan procedure.
BACKGROUND Diagnostic evaluation before Fontan procedure has typically included cardiac catheterization.
However, the overall management strategy for patients with functional single ventricle has
evolved to include staging bidirectional cavopulmonary anastomosis in most, and it has
become uncommon to exclude patients from Fontan based on catheterization data.
METHODS Patients who underwent bidirectional cavopulmonary anastomosis and had complete echo-
cardiograms and catheterizations within three months of each other between January 1992
and October 1997 were evaluated with a series of clinical and echocardiographic character-
istics to identify a subset in whom catheterization was predicted to be of little added value
(“no-cath” group). The predictive value and sensitivity of these criteria in excluding patients
who required additional intervention, were excluded from Fontan, or died within 30 days of
Fontan was determined.
RESULTS A total of 99 patients who underwent bidirectional cavopulmonary anastomosis at 6.7 months
(range 2.9 months to 14 years) were studied; 46 met criteria for the “no-cath” group.
Noninvasive criteria stratified all patients who died (n  5) or did not proceed to Fontan (n
 1) and 9 of 11 who required additional interventions to the “cath” group. Thus, the
negative predictive value of these criteria was 93%.
CONCLUSIONS Our data suggest that catheterization before Fontan could be avoided in a large percentage of
patients without adversely affecting outcome; prospective evaluation of this strategy is
warranted. (J Am Coll Cardiol 2004;44:184–7) © 2004 by the American College of
Cardiology Foundationg
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aoninvasive techniques are commonly used as the sole means
f evaluation before surgical repair of congenital heart disease.
ast studies have demonstrated the accuracy of echocardiog-
aphy alone for preoperative diagnosis in many lesions includ-
ng atrial septal defects, complete atrioventricular (AV) canal,
nd tetralogy of Fallot (1–5).
Echocardiography is also commonly used as the sole diag-
ostic modality before the first palliative procedure in patients
ith single-ventricle lesions (6,7). Diagnostic evaluation before
ontan procedure has typically included noninvasive assess-
ent with echocardiography as well as invasive hemodynamic
nd angiographic evaluation by cardiac catheterization (8,9).
he goals of this diagnostic assessment are: 1) to identify
atients in whom the Fontan operation should not be per-
ormed because of excessive risk; and 2) to identify patients in
hom additional interventions (either by catheter before sur-
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Manuscript received March 18, 2003; revised manuscript received January 7, 2004,nccepted February 24, 2004.ery or in the operating room concomitant with the Fontan
rocedure) are required.
The overall management strategy for patients with func-
ional single-ventricle heart disease has evolved since the
nunciation of the so-called Fontan laws (10). At our institu-
ion, most patients proceed to Fontan surgery after antecedent
idirectional cavopulmonary anastomosis. It has become un-
ommon to exclude patients from Fontan based on hemody-
amic parameters obtained at catheterization (11). We hy-
othesized that, after a previous bidirectional cavopulmonary
nastomosis, a subset of patients could be identified in whom
atheterization was of little added benefit before total cavopul-
onary anastomosis. Based on clinical experience we delin-
ated a series of criteria to discriminate between patients who
ould benefit from catheterization before Fontan (cath) and
hose who would not (no-cath). We then tested the value of
hese criteria in predicting either poor outcome or the need for
dditional intervention.
ETHODS
he surgical database at our institution was queried to identify
ll patients who underwent bidirectional superior cavopulmo-
ary anastomosis between January 1992 and October 1997.
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July 7, 2004:184–7 Evaluation for Fontan Without Catheterizationor inclusion in the study we required that patients have a
omplete echocardiogram performed within three months of
ardiac catheterization in anticipation of completion of the
ontan procedure. According to our laboratory standards,
omplete echocardiograms in this setting include assessment of
ystemic and pulmonary venous return, flow at the atrial
eptum, AV and semilunar valve function, ventricular perfor-
ance, pulmonary artery architecture, and aortic arch anatomy
nd flow velocity. Medical records, operative notes, and cardiac
atheterization data were reviewed. Independent observers
linded to outcomes reviewed echocardiograms and angio-
rams.
Patients were divided into those in whom catheterization
as predicted to be unnecessary (no-cath) and those who were
redicted to require catheterization (cath) before proceeding to
he Fontan operation. Patients were included in the cath group
f they met any one of the criteria, including two clinical
eatures (pulse oximetry 76%, hemoglobin concentration
18 g/dl) and six echocardiographic features (Table 1). The
linical course of all patients was reviewed to determine which
atients were subsequently excluded from proceeding to Fon-
an, required additional interventions (at catheterization or
urgery), or died within 30 days of Fontan. Predictive value and
ensitivity of the discriminating criteria were determined.
ummary data are expressed as mean (range).
ESULTS
atient population. A total of 305 patients underwent
idirectional cavopulmonary anastomosis between January
992 and October 1997. Of the total, 101 patients had an
chocardiogram and cardiac catheterizations within three
onths of each other after bidirectional cavopulmonary anas-
omosis with data available for review. In two cases, echocar-
iography studies were inadequate as defined (see the Methods
ection). Thus, the study population consisted of 99 patients.
f these, 94 patients had undergone hemi-Fontan and 5 had
ndergone bidirectional Glenn procedures. The median age at
emi-Fontan or bidirectional Glenn was 6.7 months (range
Abbreviations and Acronyms
AV  atrioventricular
NPV  negative predictive value
PPV  positive predictive value
able 1. Characteristics of Low-Risk Patients
linical data
Room air pulse oximetry 76%
Hemoglobin 18 g/dl
chocardiographic data
Left pulmonary artery visualized without stenosis
No significant atrioventricular valve insufficiency (1)
No significant ventricular dysfunction (qualitative)
No aortic coarctation
An unrestrictive atrial communication
No evidence of a decompressing vessel h.9 months to 14 years). The median age at echocardiogram
as 19.1 months (4 months to 14 years), and the median age
t cardiac catheterization was 19.1 months (4 months to 14
ears), with the median time between echocardiogram and
ardiac catheterization being one day (range 0 to 82 days). The
edian age at Fontan procedure was 21 months (range 11
onths to 14 years). A total of 46 patients met criteria for the
o-cath group, and 53 were stratified to cath. Among the latter
roup, more than one criterion was present in 12 patients
Table 2).
Because a large number of patients were excluded from this
tudy, excluded patients were compared with those in the study
opulation. The median age at hemi-Fontan or bidirectional
lenn among the 206 patients excluded from this study was
.9 months (p  NS compared with study group). Mortality
mong the excluded patients was 15% (n  31), higher than
he study population. However, this apparent difference is
xplained by the fact that most of these deaths occurred early
fter hemi-Fontan, before the age where patients would have
een eligible for entrance into this study. Of the 31 deaths, 23
ccurred before 19 months of age (the average age at cathe-
erization in this study). This leaves eight patients who died
ore than 19 months after hemi-Fontan, a mortality rate of
%, not significantly different from that in the study group.
utcomes. In 17 of the 99 patients, the subsequent course
as complicated. Five died (two before Fontan and three
fter Fontan), and one did not proceed to Fontan. Other
nterventions in addition to Fontan surgery were performed
n 11 patients; these are outlined in Table 3.
Forty-five of the 46 patients meeting no-cath criteria
roceeded to Fontan; three had additional interventions.
ne patient did not proceed, secondary to a previous
erebrovascular accident and the parents’ wish for no further
urgery. Two patients underwent coil embolization of de-
ompressing veins: one had a 2 mm left superior vena cava;
he other had a 3 mm vein to the left atrium (both patients
able 2. Characteristics Predicted to Discriminate Need for
atheterization
Characteristic
Number of Patients
Meeting Criteria
for Cath (n  53)*
linical data
Pulse oximetry 76% 8
Hemoglobin 18 g/dl 9
chocardiographic data
Left pulmonary artery not seen or stenotic 32
(19 not visualized)
(13 stenotic)
Significant atrioventricular valve
regurgitation (1)
10
Significantly diminished ventricular
contractility
6
Aortic coarctation 1
Restrictive atrial septal defect 1
Evidence of a decompressing vessel 1
Nine patients met two criteria and three patients met three criteria.ad arterial oxygen saturations over 80%). One patient had
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Evaluation for Fontan Without Catheterization July 7, 2004:184–7urgical valvuloplasty of the AV valve at the time of Fontan.
his patient had mild AV valve regurgitation by echocar-
iogram and moderate by angiography. Of the 53 patients
eeting criteria for cath, 5 died and 8 underwent additional
nterventions. The ability of these criteria to appropriately
tratify patients to cath (negative predictive value [NPV])
as 93% (95% confidence interval 86% to 100%) with 81%
ensitivity. Specificity, however, was only 52%, and the
ositive predictive value (PPV) was only 25% with many
atients stratified to catheterization in whom no pertinent
ndings emerged.
ISCUSSION
any patients were excluded from the Fontan procedure in
he early decades of its application based on selection criteria
hat could be accurately obtained only by cardiac catheter-
zation (9,10). Since then, patient population, surgical
pproach, and diagnostic tools have dramatically changed.
n our practice the vast majority of patients considered for
ontan have undergone prior bidirectional superior cavo-
ulmonary anastomosis (12). The goal of diagnostic evalu-
tion before completion of the Fontan procedure is to
dentify those few patients in whom the Fontan operation
hould not be performed, as well as those who require
dditional intervention before or at the time of Fontan.
espite these changes, current practice continues to include
ardiac catheterization before Fontan. Although catheter-
zation can be performed safely, it is not without risk.
ecent studies report complications in 5% to 10% and death
n 0.1% of diagnostic catheterizations (13,14). Catheteriza-
ion is costly and is an additional procedure for children who
re already subjected to many such procedures. Thus, we
ought to determine whether noninvasive criteria could be
sed to define a subset of patients who could forgo preop-
rative catheterization without an adverse effect on out-
ome. Eight criteria were defined, retrospectively applied,
nd evaluated for predictive value. Forty-six percent of
atients met criteria to avoid catheterization. Overall, 17%
f patients died, required additional intervention, or did not
roceed to Fontan. The selection criteria appropriately
tratified all 5 patients who died before or after Fontan
rocedure and 8 of the 11 patients who underwent addi-
ional intervention.
able 3. Additional Surgical or Transcatheter Interventions in
atients Undergoing Bidirectional Superior Cavopulmonary
nastomosis
Intervention
“No Cath”
Group
“Cath”
Group
oil embolization of decompressing vessel 2 2*
trioventricular valvuloplasty 1 3
alloon dilation of left pulmonary artery 0 3*
alloon dilation of coarctation 0 1*
trial septectomy 0 1
One patient had three interventions.Three patients who were stratified to the no-cath groupeceived additional interventions: small decompressing veins
ere embolized in two patients, and one patient underwent
alvuloplasty at the time of Fontan. It is not possible to
efinitively assess the importance of these interventions.
owever, it is unlikely that failure to embolize the decom-
ressing veins would have resulted in excess cyanosis after
ontan; in both instances the vessels originated from the
uperior cavopulmonary circuit, and neither patient had an
nusually low arterial saturation before Fontan.
Overall, the ability of our criteria to discriminate patients
ho could forgo catheterization (NPV) was acceptable
93%). However, the positive predictive value of this strat-
gy was rather low; the majority of patients stratified to
ndergo catheterization required no additional intervention
nd had unremarkable courses at Fontan. The limited
bility of echocardiography to adequately assess branch
ulmonary artery architecture contributed to this poor
redictive value (19% of cases). Application of magnetic
esonance imaging to these cases would substantially im-
rove PPV of these criteria.
Other important limitations of this work should be
oted. This study is retrospective and subject to all short-
omings inherent in retrospective analyses. We chose as
utcomes the need for any additional intervention and
eaths. We did not attempt to determine to what extent
atheterization predicted these outcomes. This approach
as taken because we reasoned that attempts at such
eterminations would be too subject to bias in a retrospec-
ive analysis. Clearly a prospective evaluation of this man-
gement strategy must follow before its generalized appli-
ation. Finally, it should be noted that at our institution coil
mbolization of small systemic to pulmonary arteries (com-
only found in this patient group) is not routinely per-
ormed before Fontan. Some have suggested that the
resence of collaterals correlates with worse outcome after
ontan and, therefore, they routinely embolize these vessels
15,16). These findings have not been reproduced in other
tudies (17). We reserve this intervention for instances with
bundant collateral flow and hemodynamic evidence of their
ignificance: high pulmonary artery pressure or elevated
entricular filling pressure. It seems unlikely that noninva-
ive criteria would correctly identify patients with more
xtensive collaterals. In spite of these limitations, our data
uggest that catheterization before Fontan could be avoided
n a large percentage of patients. We suggest that prospec-
ive evaluation of this strategy is warranted.
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